3ZYA | pdb_00003zya

Human p38 MAP Kinase in Complex with 2-amino-phenylamino- dibenzosuberone


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.209 (Depositor), 0.206 (DCC) 
  • R-Value Work: 
    0.171 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 
    0.172 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3ZYA

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Skepinone-L is a Selective P38 Mitogen-Activated Protein Kinase Inhibitor.

Koeberle, S.C.Romir, J.Fischer, S.Koeberle, A.Schattel, V.Albrecht, W.Grutter, C.Werz, O.Rauh, D.Stehle, T.Laufer, S.A.

(2011) Nat Chem Biol 8: 141

  • DOI: https://doi.org/10.1038/nchembio.761
  • Primary Citation Related Structures: 
    3QUE, 3ZYA

  • PubMed Abstract: 

    Until now, a lack of inhibitors with high potency and selectivity in vivo has hampered investigation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We describe the design of skepinone-L, which is, to our knowledge, the first ATP-competitive p38 MAPK inhibitor with excellent in vivo efficacy and selectivity. Therefore, skepinone-L is a valuable probe for chemical biology research, and it may foster the development of a unique class of kinase inhibitors.


  • Organizational Affiliation
    • Institute of Pharmacy, University of Tübingen, Tübingen, Germany.

Macromolecule Content 

  • Total Structure Weight: 42.31 kDa 
  • Atom Count: 3,161 
  • Modeled Residue Count: 346 
  • Deposited Residue Count: 366 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
MITOGEN-ACTIVATED PROTEIN KINASE 14366Homo sapiensMutation(s): 0 
EC: 2.7.11.24
UniProt & NIH Common Fund Data Resources
Find proteins for Q16539 (Homo sapiens)
Explore Q16539 
Go to UniProtKB:  Q16539
PHAROS:  Q16539
GTEx:  ENSG00000112062 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ16539
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
2A8

Query on 2A8



Download:Ideal Coordinates CCD File
B [auth A]2-AMINO-PHENYLAMINO-DIBENZOSUBERONE
C21 H18 N2 O
VMANCBCSTYKPPA-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
2A8 BindingDB:  3ZYA Kd: 7.6 (nM) from 1 assay(s)
IC50: min: 50, max: 3800 (nM) from 4 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.209 (Depositor), 0.206 (DCC) 
  • R-Value Work:  0.171 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 0.172 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 47.155α = 90
b = 51.863β = 90
c = 167.881γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2011-12-28
    Type: Initial release
  • Version 1.1: 2012-02-01
    Changes: Other
  • Version 1.2: 2023-12-20
    Changes: Data collection, Database references, Derived calculations, Other, Refinement description